Cite

HARVARD Citation

    Gauvain, K. et al. (2018). 18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors. Neuro-oncology practice. 5 (1), pp. 28-36. [Online]. 
  
Back to record